PedAM
Pediatric Disease Annotations & Medicines
| Disease | hepatitis c |
| Symptom | C0019189|chronic hepatitis |
| Sentences | 26 |
| PubMedID- 23971016 | Alcohol is a strong cofactor for adverse outcomes of hepatitis c; alaska natives with chronic hepatitis c are 17 times more likely to die of liver-related causes than people in the rest of the united states. |
| PubMedID- 25091289 | Methods: a total of 343 chronic hepatitis patients infected with hepatitis c virus (hcv) genotype 2 (2a: n = 195; 2b: n = 148) were enrolled in this study. |
| PubMedID- 24631902 | Prospective evaluation of fibrotest(r), fibrometer(r), and hepascore(r) for staging liver fibrosis in chronic hepatitis b: comparison with hepatitis c. |
| PubMedID- 23986848 | This 70-year-old woman with chronic hepatitis due to hepatitis c virus infection had had recurrent episodes of hepatic encephalopathy despite protein restriction and the administration of lactulose and branched-chain amino acids. |
| PubMedID- 21979218 | Could trastuzumab suppress hepatitis c virus in a patient with chronic hepatitis and breast cancer. |
| PubMedID- 24324359 | A retrospective review of electronic medical records of treatment-naïve hepatitis c patients with chronic hepatitis c confirmed by hcv-rna referred between 2001 and 2009 for hepatitis c management to a single tertiary center was conducted. |
| PubMedID- 25755401 | Treatment of chronic hepatitis due to hepatitis c virus (ch-c) in india: a randomized controlled trial comparing daily interferon-alfa-2b and ribavirin with daily interferon-alfa-2b and glycyrrhizin-a multicenter study. |
| PubMedID- 21452540 | hepatitis c leads to chronic hepatitis in 2/3 to 3/4 of cases. |
| PubMedID- 22836284 | Background: chronic hepatitis because of the hepatitis c virus (chc) is a major health problem that can lead to decompensated cirrhosis, hepatocellular carcinoma, and eventually death, all of which are associated with significant healthcare costs. |
| PubMedID- 23360282 | All samples were negative for hiv or hepatitis c. subjects classified with acute or chronic hepatitis a or b (3 ptsd patients and 3 controls) were excluded from the study, reducing the initially enrolled sample of 44 individuals with ptsd and 39 controls to 35 ptsd patients and 25 control participants. |
| PubMedID- 21410059 | Non-invasive evaluation of liver fibrosis using acoustic radiation force impulse imaging in chronic hepatitis patients with hepatitis c virus infection. |
| PubMedID- 22098550 | Risk factors include chronic hepatitis b (estimated prevalence of 12%), chronic hepatitis c (at least 2% prevalence), and heavy consumption of alcohol among men. |
| PubMedID- 26195123 | 1distribution of patients included in the studytable 1baseline characteristics of patients in the treatment and control groupscharacteristicsindomethacin group(n = 82)glycerin group(n = 84)pfemalemale51 (62.19 %)31 (37.80 %)59 (70.23 %)25 (29.76 %)0.273age (years)51.59 ± 18.5554.0 ± 17.850.394outpatients46450.74hospitalized3639without comorbidity56540.427comorbid conditions2630 diabetes mellitus type 21214 hypertension77 dyslipidemia22 hypothyroidism10 copd11 hepatic cirrhosisa12 ischemic heart disease11 hiv01 asthma12normal total bilirubin pre-ercp26240.660elevated total bilirubin pre-ercp5660previous cholecystectomy42400.643dilated bile duct by imaging studies pre-ercp56620.506post-ercp diagnostics0.35 choledocolithiasis3432 begin biliary stenosis and/or leakage1814 suspected sphincter of oddi dysfunction1215 normal cholangiogram and/or pancreatogram811 malignant biliary tract stenosis89 pancreatic fistula23pre-ercp amylase level (u/l)57.39 ± 21.5655.36 ± 20.770.540aetiology in the indomethacin group: chronic hepatitis due to hepatitis c virus in 1 patient. |
| PubMedID- 21633525 | Mallory-denk bodies (mdb) are important as investigators, suggesting mdb as an indicator of the histologic severity of chronic hepatitis, causes of which include hepatitis c, primary biliary cirrhosis (pbc), and nonalcoholic fatty liver disease (nafld). |
| PubMedID- 25764673 | Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis c virus infection for the fiscal year 2014 in japan. |
| PubMedID- 22440563 | Many chronic hepatitis patients with hepatitis c virus (hcv) are observed to have a degree of steatosis which is a factor in the progression of liver diseases. |
| PubMedID- 22102387 | We classified pathological findings on chronic hepatitis in patients with chronic hepatitis c into minimal, mild, moderate, and severe chronic hepatitis, according to scheuer's scoring system,16 and assessed the effect of occult hbv infection of hepatitis c disease severity. |
| PubMedID- 23639983 | High prevalence of occult hepatitis c virus infection in patients with chronic hepatitis b virus infection. |
| PubMedID- 26187292 | However, the enrolled subjects in some studies have also included chronic hepatitis b patients with chronic hepatitis c coinfection or other etiologies of liver diseases. |
| PubMedID- 22186743 | Soluble urokinase plasminogen activator receptor in chronic hepatitis due to hepatitis c virus. |
| PubMedID- 23986831 | This 60-year-old man suffered from chronic hepatitis due to hepatitis c virus infection since undergoing a right hepatic lobectomy for hepatocellular carcinoma 5 months earlier. |
| PubMedID- 21677334 | Chronic alcohol abuse (29%) and chronic hepatitis due to hepatitis c virus (hcv) infection (20%) were the most common causes of cirrhosis. |
| PubMedID- 25778685 | Methods: chronic hepatitis patients with genotype 1b hepatitis c virus (hcv) infection showing serum hcv-rna levels greater than 5 log iu/ml received oral administration of cholecalciferol (2000 iu/day) or alfacalcidol (0.5 mug/day) for 4 weeks, and then they were given pegylated interferon (peg-ifn)-alpha2a plus ribavirin therapy in combination with either vitamin d3 for 48 or 72 weeks according to the response-guided manner. |
| PubMedID- 20347177 | Background & aims: progressive deposition of liver fibrosis is a common feature of chronic hepatitis associated with hepatitis c virus (hcv) infection, and it may eventually lead to cirrhosis and liver failure. |
| PubMedID- 24063897 | chronic hepatitis due to the hepatitis c virus (hcv) infection affects nearly 180 million people worldwide. |
| PubMedID- 22658873 | Background: the recommended standard therapeutic regimen for chronic hepatitis patients with hepatitis c virus (hcv) genotype 3 is pegylated interferon plus ribavirin for 24 weeks. |
Page: 1